EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies

Ronny Vargas, Noelia Martinez-Martinez, Catalina Lizano-Barrantes, Jorge Andrés Pacheco-Molina, Encarna García-Montoya, Pilar Pérez-Lozano, Josep Mª Suñé-Negre, Carlos Suñé, Marc Suñé-Pou

ADMET and DMPK · 19.10.2025 · 2988

DOI: 10.5599/admet.2988 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift ADMET and DMPK, online erschienen am 19.10.2025. Verfasst von Ronny Vargas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Costa Rica, Direcció General de Recerca, Generalitat de Catalunya, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose: The delivery of therapeutics to the central nervous system (CNS) remains a major challenge due to the restrictive nature of the blood-brain barrier (BBB), a key evolutionary feature that preserves brain homeostasis. This review seeks to synthesize current knowledge on BBB composition, physiology, and transport mechanisms, and critically analyses drug delivery strategies aimed at overcoming this barrier and enabling effective CNS therapies. Approach: We conducted a comprehensive narrative review integrating evidence on BBB anatomy, transport and permeability mechanisms, drug delivery optimization strategies, with a particular focus on nanotechnology-based systems, and preclinical evaluation models. Key results: We highlight how a deeper understanding of BBB architecture and dynamic regulation can inform rational design of targeted strategies. Drug delivery approaches are summarized and compared, with emphasis on the potential of nanotechnology-based platforms to enhance CNS drug delivery. Translational considerations, including scalability, reproducibility, and regulatory requirements, are critically addressed. Major challenges identified include receptor saturation, competition with endogenous ligands, disease-specific variability in BBB permeability, and the limited predictive value of current preclinical models. Emerging tools, such as organ-on-chip (for evaluation) and microfluidic mixing (for manufacturing nanomaterials), offer promising means to improve physiological relevance and accelerate translation. Conclusion: Progress in BBB research has laid the groundwork for innovative therapies, but significant hurdles remain. Advancing CNS drug delivery will require collaborative work refining transport-targeting mechanisms, developing standardized preclinical models, and integrating fundamental research, applied nanomedicine, and regulatory science to open new opportunities for treating neurological and psychiatric disorders and brain tumours.

Schlagwörter

Stichwörter der Autor:innen

Brain deliverycentral nervous systemlipid nanoparticlestargeted therapy

Autor:innen und Institutionen

  • Department of Pharmacy and Pharmaceutical Technology, and Physical Chemistry, Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.
  • Department of Industrial Pharmacy, Faculty of Pharmacy, Universidad de Costa Rica, San José, Costa Rica.
  • Department of Molecular Biology, Institute of Parasitology and Biomedicine "López-Neyra" (IPBLN-CSIC), Granada, Spain.
  • Department of Pharmaceutical Care and Clinical Pharmacy, Faculty of Pharmacy, Universidad de Costa Rica, San José, Costa Rica.
  • Pharmacotherapy, Pharmacogenetics and Pharmaceutical Technology Research Group Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.

Förderung

  • Universidad de Costa Rica
  • Direcció General de Recerca, Generalitat de Catalunya
  • Ministerio de Ciencia e Innovación

Zitieren

APA

Vargas, R., Martinez-Martinez, N., Lizano-Barrantes, C., Pacheco-Molina, J. A., García-Montoya, E., Pérez-Lozano, P., Suñé-Negre, J. M., Suñé, C., & Suñé-Pou, M. (2025). Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies. ADMET and DMPK, 2988. https://doi.org/10.5599/admet.2988

Vancouver

Vargas R, Martinez-Martinez N, Lizano-Barrantes C, Pacheco-Molina JA, García-Montoya E, Pérez-Lozano P, et al. Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies. ADMET and DMPK. 2025:2988. doi:10.5599/admet.2988

BibTeX
@article{Vargas2025,
  author = {Vargas, Ronny and Martinez-Martinez, Noelia and Lizano-Barrantes, Catalina and Pacheco-Molina, Jorge Andrés and García-Montoya, Encarna and Pérez-Lozano, Pilar and Suñé-Negre, Josep Mª and Suñé, Carlos and Suñé-Pou, Marc},
  title = {Advancing through the blood-brain barrier: mechanisms, challenges and drug delivery strategies},
  journal = {ADMET and DMPK},
  year = {2025},
  pages = {2988},
  doi = {10.5599/admet.2988}
}
Kostenlos starten →